Zimmer Biomet Holdings – Consensus Indicates Potential 26.5% Upside
Zimmer Biomet Holdings found using ticker (ZBH) have now 19 analysts covering the stock. The analyst consensus points to a rating of ''Hold''. The target price ranges between 145 and 114 calculating the mean target price we have 128.58. With the stocks previous close at 101.65 this indicates there is a potential upside of 26.5%. The 50 day MA is 112.3 and the 200 moving average now moves to 122.69. The market cap for the company is $21,693m. Visit the company website at: https:||www.zimmerbiomet.com [stock_market_widget type="chart" template="basic" color="green" assets="ZBH" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $27,440m based on the market concensus. Zimmer Biomet Holdings, together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products
Zimmer Biomet Holdings – Consensus Indicates Potential 26.5% Upside
Zimmer Biomet Holdings found using ticker (ZBH) have now 19 analysts covering the stock. The analyst consensus points to a rating of ''Hold''. The target price ranges between 145 and 114 calculating the mean target price we have 128.58. With the stocks previous close at 101.65 this indicates there is a potential upside of 26.5%. The 50 day MA is 112.3 and the 200 moving average now moves to 122.69. The market cap for the company is $21,693m. Visit the company website at: https:||www.zimmerbiomet.com [stock_market_widget type="chart" template="basic" color="green" assets="ZBH" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $27,440m based on the market concensus. Zimmer Biomet Holdings, together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products